SMAD2/3 Phosphorylation Is Downregulated in T Cells in HIV-Infected Patients

AIDS Res Hum Retroviruses. 2023 Mar;39(3):99-103. doi: 10.1089/AID.2021.0212. Epub 2023 Jan 4.

Abstract

Persistent inflammation contributes to the exhaustion of immune system and non-AIDS-defining events in HIV-infected patients. Transforming growth factor β (TGF-β) is generally considered an anti-inflammatory cytokine. It is unclear that why high-level TGF-β coexists with chronic inflammation during HIV infection. In this study, it was found that HIV-infected patients had lower proportion of phosphorylated SMAD2/3-positive cells among total CD3+ T cells and subsets of CD3+CD8+ and CD3+CD8- T cells when compared with health subjects. The findings implied that phosphorylation of SMAD2/3 is inhibited in HIV-infected patients, and that disturbance of TGF-β/SMAD2/3 signaling pathway may be involved in HIV-related chronic inflammation.

Keywords: AIDS; HIV; SMAD2/3; TGF-β; inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV Infections*
  • Humans
  • Inflammation
  • Phosphorylation
  • Signal Transduction*
  • Smad2 Protein / metabolism
  • T-Lymphocytes* / metabolism
  • Transforming Growth Factor beta

Substances

  • Smad2 Protein
  • SMAD2 protein, human
  • Transforming Growth Factor beta
  • SMAD3 protein, human